Orphan nuclear receptor COUP-TFII is an oncogenic gene in renal cell carcinoma
- 31 July 2019
- journal article
- research article
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 22 (5) , 772-781
Abstract
Background Chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) may be an oncogenic gene in renal cell carcinoma (RCC). However, the direct association between COUP-TFII expression and patient survival has not been investigated in patients with RCC, and the molecular oncogenesis of COUP-TFII in RCC remains unclear. Methods The mRNA expression levels of COUP-TFII in the tumors of 283 patients with RCC were determined by RT-qPCR. The remaining 266 patients were categorized into low- and high-expression groups according to the cut off value generated by receiver operating curve (ROC) analysis. The function of COUP-TFII in RCC cells was tested by knockdown experiments in vitro. Results In the present study, it was revealed that the mRNA expression levels of COUP-TFII were significantly higher in tumors compared with those in adjacent non-cancerous tissues, and that the overexpression of COUP-TFII was strongly associated with poor patient survival. It was further demonstrated that knockdown of COUP-TFII suppressed proliferation, and induced apoptosis and cell cycle arrest in RCC cells in vitro. This also resulted in the activation of the mitochondria-mediated apoptosis pathway, impaired migration and invasion of RCC cells through epithelial–mesenchymal transition in vitro, and suppressed tumor growth in vivo. In addition, it was revealed that the induction of cell migration and invasion by COUP-TFII was mediated, at least in part, by integrin subunit β1. Conclusions In summary, the present study indicated that COUP-TFII is an oncogenic gene in RCC, and a potential therapeutic target for the treatment of the disease.Keywords
This publication has 20 references indexed in Scilit:
- Knockdown of COUP‐TFII inhibits cell proliferation and induces apoptosis through upregulating BRCA1 in renal cell carcinoma cellsInternational Journal of Cancer, 2016
- Dysregulation of miRNAs-COUP-TFII-FOXM1-CENPF axis contributes to the metastasis of prostate cancerNature Communications, 2016
- Expression and Functional Pathway Analysis of Nuclear Receptor NR2F2 in Ovarian CancerThe Journal of Clinical Endocrinology & Metabolism, 2013
- Research Resource: Nuclear Receptors as Transcriptome: Discriminant and Prognostic Value in Breast CancerMolecular Endocrinology, 2013
- Nuclear Receptor COUP-TFII Controls Pancreatic Islet Tumor Angiogenesis by Regulating Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor-2 SignalingCancer Research, 2010
- COUP-TFII regulates tumor growth and metastasis by modulating tumor angiogenesisProceedings of the National Academy of Sciences, 2010
- COUP-TFI modulates estrogen signaling and influences proliferation, survival and migration of breast cancer cellsBreast Cancer Research and Treatment, 2007
- Decreased Chicken Ovalbumin Upstream Promoter Transcription Factor II Expression in Tamoxifen-Resistant Breast Cancer CellsCancer Research, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Chicken Ovalbumin Upstream Promoter-Transcription Factor Interacts with Estrogen Receptor, Binds to Estrogen Response Elements and Half-Sites, and Inhibits Estrogen-induced Gene ExpressionJournal of Biological Chemistry, 1997